50
Participants
Start Date
January 31, 2011
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2013
etanercept
Discontinuation of etanercept (half of the dosis for 3 months and discontinuation thereafter)
etanercept
Continuation of etanercept for another 9 months, and, if still meeting the eligibility criteria, discontinuation of etanercept thereafter.
NOT_YET_RECRUITING
Academic Medical Centre Emma Children's Hospital, Amsterdam
NOT_YET_RECRUITING
Reade Institute Amsterdam, Amsterdam
ACTIVE_NOT_RECRUITING
Sint-Lucas Andreas Hospital, Amsterdam
NOT_YET_RECRUITING
University Medical Centre Groningen, Groningen
NOT_YET_RECRUITING
Leiden University Medical Center, Leiden
NOT_YET_RECRUITING
Maastricht University Medical Centre, Maastricht
NOT_YET_RECRUITING
St Maartenskliniek, Nijmegen
RECRUITING
Erasmus MC Sophia Children's Hospital, Rotterdam
NOT_YET_RECRUITING
Haga Hospital, Juliana Children's Hospital, The Hague
NOT_YET_RECRUITING
Utrecht Medical Centre Wilhelmina Children's Hospital, Utrecht
Lead Sponsor
Dutch Arthritis Association
INDUSTRY
Erasmus Medical Center
OTHER